Cited by 511Barrier Structure and Function StudiesCerebrospinal fluid and hydrocephalusDrug Transport and Resistance Mechanisms

The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.

CSF, blood-brain barrier, and brain drug delivery

Pardridge, William M.·2016·Expert Opinion on Drug Delivery

DOI 10.1517/17425247.2016.1171315

Open this paper in CoChat — free account

Abstract

INTRODUCTION: There are 2 misconceptions about the cerebrospinal fluid (CSF), the blood-brain barrier (BBB), and brain drug delivery, which date back to the discovery of a barrier between blood and brain over 100 years ago. Misconception 1 is that drug distribution into CSF is a measure of BBB transport. Misconception 2 is that drug injected into the CSF compartment distributes to the inner parenchyma of brain. AREAS COVERED: Drug distribution into the CSF is a function of drug transport across the choroid plexus, which forms the blood-CSF barrier, and not drug transport across the BBB, which is situated at the microvascular endothelium of brain. Drug injected into CSF undergoes rapid efflux to the blood compartment via bulk flow. Drug penetration into brain parenchyma from the CSF is limited by diffusion and drug concentrations in brain decrease exponentially relative to the CSF concentration. EXPERT OPINION: The barrier between blood and brain was discovered in 1913, when it was believed that the BBB was localized to the choroid plexus, and that nutrient flow from blood passed through the CSF en route to brain. These misconceptions are still widely held, and hinder progress in the development of technology for BBB drug delivery.

Integrity signals

Registry

Crossref · 10.1517/17425247.2016.1171315

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

null
null (2016) · Philosophy Study · doi:10.17265/2159-5313/2016.09.003 · Cited by 28,317
A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β
Iliff, J. J., Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., Vates, G. E., Deane, R., Goldman, S. A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003748 · Cited by 5,824
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,776
JUNCTIONS BETWEEN INTIMATELY APPOSED CELL MEMBRANES IN THE VERTEBRATE BRAIN
Brightman, M., & Reese, T. S. (1969) · The Journal of Cell Biology · doi:10.1083/jcb.40.3.648 · Cited by 2,457
The Permeability of Capillaries in Various Organs as Determined by Use of the ‘Indicator Diffusion’ Method
Crone, C. (1963) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1963.tb02652.x · Cited by 1,157
Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study.
Butt, A. M., Jones, H. C., & Abbott, N. J. (1990) · The Journal of Physiology · doi:10.1113/jphysiol.1990.sp018243 · Cited by 775
Evidence for a ‘Paravascular’ fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space
Rennels, M. L., Gregory, T. F., Blaumanis, O. R., Fujimoto, K., & Grady, P. A. (1985) · Brain Research · doi:10.1016/0006-8993(85)91383-6 · Cited by 752
Principles of neural science
de Jong, J. M. B. V. (1986) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(86)90083-3 · Cited by 666
Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization.
Pardridge, W. M., Boado, R. J., & Farrell, C. R. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)38267-x · Cited by 606
Self-citation
Radioimmunotherapy of human tumours
Larson, S. M., Carrasquillo, J. A., Cheung, N. V., & Press, O. W. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3925 · Cited by 540

Show all 88 references

Research works printed but not linked: 11

Verrees M, 2004, Am Fam Physician, 70, 1071
Poplack DG, 1977, Cancer Res, 37, 1982
Brightman MW, 1993, The blood-brain barrier, 107
Anderson JM, 2001, News Physiol Sci, 16, 126
Reiber H, 2003, Restor Neurol Neurosci, 21, 79
Pardridge WM, 1985, Am J Physiol, 249, E534
Covell DG, 1985, Am J Physiol, 248, R147
10.17265/2159-5313/2016.09.003 · DOI · Paper page
Morrison PF, 1994, Am J Physiol, 266, R292
Cserr HF, 1981, Am J Physiol, 240, F319
Zhang X, 1998, Neurosci, 4, 1225

Sorted by citations

The blood–brain barrier: Structure, regulation and drug delivery
Wu, D., Chen, Q., Chen, X., Han, F., Chen, Z., & Wang, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01481-w · Cited by 1,906
“After being injected through the tails of ICR (CD-1) mice, the NP showed signi ﬁ cant antinociceptive effects which means loperamide was able to be transported across BBB. Frey II et al. investigated the delivery of IGF1 to CNS, con ﬁ rming they reached CNS target sites of rats by administering a mixture of [ 125 I]-l…”
MethodInfluential
Chemogenetics revealed: DREADD occupancy and activation via converted clozapine
Gomez, J. L., Bonaventura, J., Lesniak, W., Mathews, W. B., Sysa-Shah, P., Rodriguez, L. A., Ellis, R. J., Richie, C. T., Harvey, B. K., Dannals, R. F., et al. (2017) · Science · doi:10.1126/science.aan2475 · Cited by 980
Blood-brain barrier opening in Alzheimer’s disease using MR-guided focused ultrasound
Lipsman, N., Meng, Y., Bethune, A. J., Huang, Y., Lam, B., Masellis, M., Herrmann, N., Heyn, C., Aubert, I., Boutet, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04529-6 · Cited by 950
Next generation antibody drugs: pursuit of the 'high-hanging fruit'
Carter, P. J., & Lazar, G. A. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.227 · Cited by 780
3D self-organized microvascular model of the human blood-brain barrier with endothelial cells, pericytes and astrocytes
Campisi, M., Shin, Y., Osaki, T., Hajal, C., Chiono, V., & Kamm, R. D. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.07.014 · Cited by 718
EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours
Le Rhun, E., Weller, M., Brandsma, D., Van den Bent, M., de Azambuja, E., Henriksson, R., Boulanger, T., Peters, S., Watts, C., Wick, W., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx221 · Cited by 637
Drug delivery to the central nervous system
Nance, E. A., Pun, S. H., Saigal, R., & Sellers, D. L. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00394-w · Cited by 442
Blood-Brain Barrier and Delivery of Protein and Gene Therapeutics to Brain
Pardridge, W. M. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00373 · Cited by 405
Self-citation
Breaking Down the Barriers to Precision Cancer Nanomedicine
von Roemeling, C., Jiang, W., Chan, C. K., Weissman, I. L., & Kim, B. Y. S. (2017) · Trends in Biotechnology · doi:10.1016/j.tibtech.2016.07.006 · Cited by 330
Blood–brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy
Galstyan, A., Markman, J. L., Shatalova, E. S., Chiechi, A., Korman, A. J., Patil, R., Klymyshyn, D., Tourtellotte, W. G., Israel, L. L., Braubach, O., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11719-3 · Cited by 311
The blood–tumour barrier in cancer biology and therapy
Steeg, P. S. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00529-6 · Cited by 309
Cytokines in CAR T Cell–Associated Neurotoxicity
Gust, J., Ponce, R. A., Liles, W. C., Garden, G. A., & Turtle, C. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.577027 · Cited by 279
Applications of Phyto-Nanotechnology for the Treatment of Neurodegenerative Disorders
Bhattacharya, T., Soares, G. A. B. E., Chopra, H., Rahman, M. M., Hasan, Z., Swain, S. S., & Cavalu, S. D. (2022) · Materials · doi:10.3390/ma15030804 · Cited by 267
Blood–Brain Barrier in Brain Tumors: Biology and Clinical Relevance
Mo, F., Pellerino, A., Soffietti, R., & Rudà, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312654 · Cited by 257
The glymphatic hypothesis: the theory and the evidence
Hladky, S. B., & Barrand, M. A. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-021-00282-z · Cited by 283
A Historical Review of Brain Drug Delivery
Pardridge, W. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061283 · Cited by 219
Self-citation
Targeted drug delivery to the brain via intranasal nanoemulsion: Available proof of concept and existing challenges
Chatterjee, B., Gorain, B., Mohananaidu, K., Sengupta, P., Mandal, U. K., & Choudhury, H. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.05.032 · Cited by 223
Effective and Targeted Human Orthotopic Glioblastoma Xenograft Therapy via a Multifunctional Biomimetic Nanomedicine
Zou, Y., Liu, Y., Yang, Z., Zhang, D., Lu, Y., Zheng, M., Xue, X., Geng, J., Chung, R., & Shi, B. (2018) · Advanced Materials · doi:10.1002/adma.201803717 · Cited by 203
Immunotherapy for glioblastoma: the promise of combination strategies
Bausart, M., Véronique Préat, A., & Malfanti, A. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02251-2 · Cited by 205
Treatment of Alzheimer’s Disease and Blood–Brain Barrier Drug Delivery
Pardridge, W. M. (2020) · Pharmaceuticals · doi:10.3390/ph13110394 · Cited by 198
Self-citation
Blood-Brain Barrier, Blood-Brain Tumor Barrier, and Fluorescence-Guided Neurosurgical Oncology: Delivering Optical Labels to Brain Tumors
Belykh, E. G., Shaffer, K. V., Lin, C., Byvaltsev, V. A., Preul, M. C., & Chen, L. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00739 · Cited by 200
Intrathecal drug delivery in the era of nanomedicine
Fowler, M. J., Cotter, J. D., Knight, B. E., Sevick-Muraca, E. M., Sandberg, D. I., & Sirianni, R. W. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.02.006 · Cited by 187
Overcoming the blood–brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches
Mitusova, K. A., Peltek, O. O., Karpov, T. E., Muslimov, A. R., Zyuzin, M. V., & Timin, A. S. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01610-7 · Cited by 193
Nanoparticle Drug Delivery System for Glioma and Its Efficacy Improvement Strategies: A Comprehensive Review
Li, J., Zhao, J., Tan, T., Liu, M., Zeng, Z., Zeng, Y., Zhang, L., Fu, C., Chen, D., & Xie, T. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s243223 · Cited by 182
Localized blood–brain barrier opening in infiltrating gliomas with MRI-guided acoustic emissions–controlled focused ultrasound
Anastasiadis, P., Gandhi, D., Guo, Y., Ahmed, A.-K., Bentzen, S. M., Arvanitis, C., & Woodworth, G. F. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2103280118 · Cited by 182
SLC and ABC Transporters: Expression, Localization, and Species Differences at the Blood-Brain and the Blood-Cerebrospinal Fluid Barriers
Morris, M. E., Rodriguez‐Cruz, V., & Felmlee, M. A. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0110-8 · Cited by 188
Management of brain metastases according to molecular subtypes
Soffietti, R., Ahluwalia, M. S., Lin, N., & Rudà, R. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0391-x · Cited by 175
Delivery of the Brainshuttle™ amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humans
Grimm, H. P., Schumacher, V. L., Schäfer, M. K.-H., Imhof-Jung, S., Freskgård, P., Brady, K., Hofmann, C., Rüger, P., Schlothauer, T., Göpfert, U., et al. (2023) · mAbs · doi:10.1080/19420862.2023.2261509 · Cited by 180
AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease
Rosenberg, J. B., Kaplitt, M. G., De, B. P., Chen, A., Flagiello, T., Salami, C., Pey, E., Zhao, L., Ricart Arbona, R. J., Monette, S., et al. (2018) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2017.231 · Cited by 176
Reviewing the Significance of Blood–Brain Barrier Disruption in Multiple Sclerosis Pathology and Treatment
Bălașa, R., Bărcuţean, L., Mosora, O., & Manu, D. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168370 · Cited by 169
Nanomaterials for Drug Delivery to the Central Nervous System
Teleanu, D. M., Neguț, I., Grumezescu, V., Grumezescu, A. M., & Teleanu, R. I. (2019) · Nanomaterials · doi:10.3390/nano9030371 · Cited by 161
Emerging innate biological properties of nano-drug delivery systems: A focus on PAMAM dendrimers and their clinical potential
Kheraldine, H., Rachid, O., Habib, A. M., Moustafa, A. A., Benter, I. F., & Akhtar, S. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113908 · Cited by 152
Delivery of Biologics Across the Blood–Brain Barrier with Molecular Trojan Horse Technology
Pardridge, W. M. (2017) · BioDrugs · doi:10.1007/s40259-017-0248-z · Cited by 152
Self-citation
Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrier
Barker, S. J., Thayer, M. B., Kim, C., Tatarakis, D., Simon, M. J., Dial, R., Nilewski, L., Wells, R. C., Zhou, Y., Afetian, M., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adi2245 · Cited by 142
The choroid plexus: a missing link in our understanding of brain development and function
Saunders, N. R., Dzięgielewska, K. M., Fame, R. M., Lehtinen, M. K., & Liddelow, S. A. (2022) · Physiological Reviews · doi:10.1152/physrev.00060.2021 · Cited by 145
AAV vectors applied to the treatment of CNS disorders: Clinical status and challenges
Kang, L., Jin, S., Wang, J., Lv, Z., Xin, C., Tan, C., Zhao, M., Wang, L., & Liu, J. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.067 · Cited by 131
Blood–Brain Barrier Transport of Transferrin Receptor-Targeted Nanoparticles
Thomsen, M. S., Johnsen, K. B., Kucharz, K., Lauritzen, M., & Moos, T. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102237 · Cited by 135
Synthesis, characterization, X-ray, HOMO-LUMO, MEP, FT-IR, NLO, Hirshfeld surface, ADMET, boiled-egg model properties and molecular docking studies with human cyclophilin D (CypD) of a Schiff base compound: (E)-1-(5-nitro-2-(piperidin-1-yl)phenyl)-N-(3-nitrophenyl)methanimine
Şahin, S., & Dege, N. (2021) · Polyhedron · doi:10.1016/j.poly.2021.115320 · Cited by 129
The barrier and interface mechanisms of the brain barrier, and brain drug delivery
Zhang, S., Gan, L., Cao, F., Wang, H., Gong, P., Ma, C., Ren, L., Lin, Y., & Lin, X. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.09.017 · Cited by 129
ABC Transporters at the Blood–Brain Interfaces, Their Study Models, and Drug Delivery Implications in Gliomas
Gomez‐Zepeda, D., Taghi, M., Scherrmann, J., Declèves, X., & Menet, M. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics12010020 · Cited by 131
Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment
Pearson, J. R. D., Cuzzubbo, S., McArthur, S., Durrant, L. G., Adhikaree, J., Tinsley, C. J., Pockley, A. G., & McArdle, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.582106 · Cited by 118
Brain-derived neurotrophic factor delivered to the brain using poly (lactide-co-glycolide) nanoparticles improves neurological and cognitive outcome in mice with traumatic brain injury
Khalin, I., Alyautdin, R. N., Wong, T. W., Gnanou, J. V., Kocherga, G., & Kreuter, J. (2016) · Drug Delivery · doi:10.1080/10717544.2016.1199609 · Cited by 121
Approaches to CNS Drug Delivery with a Focus on Transporter-Mediated Transcytosis
Razzak, R. A., Florence, G. J., & Gunn‐Moore, F. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20123108 · Cited by 118
Microfluidic Electrochemical Sensor for Cerebrospinal Fluid and Blood Dopamine Detection in a Mouse Model of Parkinson’s Disease
Şenel, M., Dervisevic, E., Alhassen, S., Dervisevic, M., Alachkar, A., Cadarso, V. J., & Voelcker, N. H. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c02032 · Cited by 114
Targeted delivery of a STING agonist to brain tumors using bioengineered protein nanoparticles for enhanced immunotherapy
Wang, B., Tang, M., Yuan, Z., Li, Z., Hu, B., Bai, X., Chu, J., Xu, X., & Zhang, X.-Q. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.02.026 · Cited by 112
In vitro Models of the Blood–Brain Barrier: Tools in Translational Medicine
Williams-Medina, A. R., Deblock, M. C., & Janigro, D. (2021) · Frontiers in Medical Technology · doi:10.3389/fmedt.2020.623950 · Cited by 114
Brain Disposition of Antibody-Based Therapeutics: Dogma, Approaches and Perspectives
Kouhi, A., Pachipulusu, V., Kapenstein, T., Hu, P., Epstein, A. L., & Khawli, L. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126442 · Cited by 109
Modeling Nanocarrier Transport across a 3D In Vitro Human Blood‐Brain–Barrier Microvasculature
Lee, S. W. L., Campisi, M., Osaki, T., Possenti, L., Mattu, C., Adriani, G., Kamm, R. D., & Chiono, V. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.201901486 · Cited by 107
Microglia-targeting nanotherapeutics for neurodegenerative diseases
Zhao, N., Francis, N. L., Calvelli, H. R., & Moghe, P. V. (2020) · APL Bioengineering · doi:10.1063/5.0013178 · Cited by 104
Glymphatic Cerebrospinal Fluid and Solute Transport Quantified by MRI and PET Imaging
Benveniste, H., Lee, H., Ozturk, B., Chen, X., Koundal, S., Vaska, P., Tannenbaum, A., & Volkow, N. D. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.11.014 · Cited by 106
Non-Invasive MRI of Blood–Cerebrospinal Fluid Barrier Function
Evans, P., Sokolska, M., Alves, A., Harrison, I. F., Ohene, Y., Nahavandi, P., Ismail, O., Miranda, E., Lythgoe, M. F., Thomas, D. L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16002-4 · Cited by 122
Engineered antibodies: new possibilities for brain PET?
Sehlin, D., & Syvänen, S. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04426-0 · Cited by 96
Harnessing cerebrospinal fluid circulation for drug delivery to brain tissues
Naseri Kouzehgarani, G., Feldsien, T., Engelhard, H. H., Mirakhur, K. K., Phipps, C., Nimmrich, V., Clausznitzer, D., & Lefebvre, D. R. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.03.002 · Cited by 95
Cerebrospinal Fluid–Basic Concepts Review
Czarniak, N., Kamińska, J., Matowicka-Karna, J., & Koper‐Lenkiewicz, O. M. (2023) · Biomedicines · doi:10.3390/biomedicines11051461 · Cited by 110
Intranasal Delivery of Mesenchymal Stem Cells-Derived Extracellular Vesicles for the Treatment of Neurological Diseases
Herman, S., Fishel, I., & Offen, D. (2021) · Stem Cells · doi:10.1002/stem.3456 · Cited by 93
Nanoparticle-Based Combinational Strategies for Overcoming the Blood-Brain Barrier and Blood-Tumor Barrier
Lim, S. H., Yee, G. T., & Khang, D. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s450853 · Cited by 99
The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals
Wang, Y., Ying, X., Xu, H., Yan, H., Li, X., & Tang, H. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s124276 · Cited by 90
Strategies for persistent retention of macromolecules and nanoparticles in the blood circulation
Takakura, Y., & Takahashi, Y. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.05.063 · Cited by 91
Antibody pharmacokinetics in rat brain determined using microdialysis
Chang, H.-Y., Morrow, K., Bonacquisti, E. E., Zhang, W., & Shah, D. K. (2018) · mAbs · doi:10.1080/19420862.2018.1473910 · Cited by 87
A translational platform PBPK model for antibody disposition in the brain
Chang, H.-Y., Wu, S., Meno‐Tetang, G. M. L., & Shah, D. K. (2019) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-019-09641-8 · Cited by 87
Efficient clearance of Aβ protofibrils in AβPP-transgenic mice treated with a brain-penetrating bifunctional antibody
Syvänen, S., Hultqvist, G., Gustavsson, T., Gumucio, A., Laudon, H., Söderberg, L., Ingelsson, M., Lannfelt, L., & Sehlin, D. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0377-8 · Cited by 85
Brain and Organ Uptake in the Rhesus Monkey in Vivo of Recombinant Iduronidase Compared to an Insulin Receptor Antibody–Iduronidase Fusion Protein
Boado, R. J., & Pardridge, W. M. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b01166 · Cited by 82
Self-citation
The mechanisms behind perivascular fluid flow
Daversin, C., Vinje, V., Mardal, K., & Rognes, M. E. (2020) · PLoS ONE · doi:10.1371/journal.pone.0244442 · Cited by 82
Photoresponsive Vaccine‐Like CAR‐M System with High‐Efficiency Central Immune Regulation for Inflammation‐Related Depression
Liu, Y., Hu, P., Zheng, Z.-H., Zhong, D., Xie, W., Tang, Z., Pan, B., Luo, J. F., Zhang, W., & Wang, X. (2021) · Advanced Materials · doi:10.1002/adma.202108525 · Cited by 81
Covalent nano delivery systems for selective imaging and treatment of brain tumors
Ljubimova, J. Y., Sun, T., Mashouf, L. A., Ljubimov, A. V., Israel, L. L., Ljubimov, V. A., Falahatian, V., & Holler, E. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.06.002 · Cited by 82
Targeting Malignant Brain Tumors with Antibodies
Razpotnik, R., Novak, N., Šerbec, V. Č., & Rajčević, U. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01181 · Cited by 80
Noninvasive delivery of an α‐synuclein gene silencing vector with magnetic resonance–guided focused ultrasound
Xhima, K., Nabbouh, F., Hynynen, K., Aubert, I., & Tandon, A. (2018) · Movement Disorders · doi:10.1002/mds.101 · Cited by 86
Imaging of intranasal drug delivery to the brain.
Veronesi, M. C., Alhamami, M., Miedema, S. B., Yun, Y., Ruiz-Cardozo, M. A., & Vannier, M. W. (2020) · PubMed · Cited by 88
Gene Therapy for Human Sensorineural Hearing Loss
Ren, Y., Landegger, L. D., & Stanković, K. M. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00323 · Cited by 78
Established and Emerging Strategies for Drug Delivery Across the Blood-Brain Barrier in Brain Cancer
Parodi, A., Rudzińska, M., Deviatkin, A. A., Soond, S. M., Baldin, A. V., & Zamyatnin, A. A. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11050245 · Cited by 81
Choroid plexus function in neurological homeostasis and disorders: The awakening of the circadian clocks and orexins
Christensen, J., Li, C. N., & Mychasiuk, R. (2022) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x221082786 · Cited by 78
Human brain solute transport quantified by glymphatic MRI-informed biophysics during sleep and sleep deprivation
Vinje, V., Zapf, B., Ringstad, G., Eide, P. K., Rognes, M. E., & Mardal, K.-A. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00459-8 · Cited by 83
Intracranial pressure elevation alters CSF clearance pathways
Vinje, V., Eklund, A., Mardal, K., Rognes, M. E., & Støverud, K.-H. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00189-1 · Cited by 78
Nanotheranostic Applications for Detection and Targeting Neurodegenerative Diseases
Kumar, A., Chaudhary, R. K., Singh, R., SINGH, S. P., Wang, S., Hoe, Z.-Y., Pan, C., Shiue, Y., Wei, D., Kaushik, A. C., et al. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00305 · Cited by 76
Mechanisms of extramedullary relapse in acute lymphoblastic leukemia: Reconciling biological concepts and clinical issues
Rouger, J., Jakobczyk, H., Debaize, L., Cousin, É., Galibert, M., Troadec, M., & Gandemer, V. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.04.003 · Cited by 76
Delivery luteolin with folacin-modified nanoparticle for glioma therapy
Wu, C., Xu, Q., Chen, X., & Liu, J. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s214585 · Cited by 80
A glance over doxorubicin based-nanotherapeutics: From proof-of-concept studies to solutions in the market
Gonçalves, M., Mignani, S. M., Rodrigues, J., & Tomás, H. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.11.016 · Cited by 76
Striatal Blood–Brain Barrier Opening in Parkinson's Disease Dementia: A Pilot Exploratory Study
Pineda‐Pardo, J. A., Gasca‐Salas, C., Fernández‐Rodríguez, B., Rodríguez‐Rojas, R., del Álamo, M., Obeso, I., Hernández‐Fernández, F., Trompeta, C., Martínez‐Fernández, R., Matarazzo, M., et al. (2022) · Movement Disorders · doi:10.1002/mds.29134 · Cited by 78
Evolving new-age strategies to transport therapeutics across the blood-brain-barrier
Choudhari, M., Hejmady, S., Narayan Saha, R., Damle, S., Singhvi, G., Alexander, A., Kesharwani, P., & Kumar Dubey, S. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120351 · Cited by 74
Assessing CSF ctDNA to Improve Diagnostic Accuracy and Therapeutic Monitoring in Breast Cancer Leptomeningeal Metastasis
Fitzpatrick, A., Iravani, M., Mills, A., Childs, L., Alaguthurai, T., Clifford, A., García-Murillas, I., Laere, S. V., Dirix, L. Y., Harries, M., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-3017 · Cited by 74
Design, optimization and pharmacokinetic evaluation of Piribedil loaded solid lipid nanoparticles dispersed in nasal in situ gelling system for effective management of Parkinson’s disease
Uppuluri, C. T., Ravi, P. R., & Dalvi, A. V. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120881 · Cited by 73
Lipid nanocapsules to enhance drug bioavailability to the central nervous system
Moura, R. P., Pacheco, C., Pêgo, A. P., Rieux, A. D., & Sarmento, B. F. C. C. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.03.042 · Cited by 74
Plasmid DNA gene therapy of the Niemann-Pick C1 mouse with transferrin receptor-targeted Trojan horse liposomes
Jiang, D., Lee, H., & Pardridge, W. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-70290-w · Cited by 72
Self-citation
Orexin 2 receptor stimulation enhances resilience, while orexin 2 inhibition promotes susceptibility, to social stress, anxiety and depression
Staton, C. D., Yaeger, J. D. W., Khalid, D., Haroun, F., Fernandez, B. S., Fernandez, J. S., Summers, B., Summers, T. R., Sathyanesan, M., Newton, S. S., et al. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.09.016 · Cited by 74
Endothelial LRP1 – A Potential Target for the Treatment of Alzheimer’s Disease
Storck, S. E., & Pietrzik, C. U. (2017) · Pharmaceutical Research · doi:10.1007/s11095-017-2267-3 · Cited by 74
The influence of the blood–brain barrier in the treatment of brain tumours
Rathi, S., Griffith, J. I. G., Zhang, W., Zhang, W., Oh, J., Talele, S., Sarkaria, J. N., & Elmquist, W. F. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13440 · Cited by 71
Choroid plexus-targeted NKCC1 overexpression to treat post-hemorrhagic hydrocephalus
Sadegh, C., Xu, H., Sutin, J. D. B., Fatou, B., Gupta, S., Pragana, A., Taylor, M., Kalugin, P. N., Zawadzki, M. E., Alturkistani, O., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.02.020 · Cited by 70
State of the science on brain insulin resistance and cognitive decline due to Alzheimer's disease
Rhea, E. M., Leclerc, M., Yassine, H. N., Capuano, A. W., Tong, H., Petyuk, V. A., Macauley, S. L., Fioramonti, X., Carmichael, O., Calon, F., et al. (2023) · Aging and disease · doi:10.14336/ad.2023.0814 · Cited by 70
Therapeutic Delivery to the Brain via the Lymphatic Vasculature
Zhao, P., Le, Z., Liu, L., & Chen, Y. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c01806 · Cited by 69
Addressing BBB Heterogeneity: A New Paradigm for Drug Delivery to Brain Tumors
Griffith, J. I. G., Rathi, S., Zhang, W., Zhang, W., Drewes, L. R., Sarkaria, J. N., & Elmquist, W. F. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121205 · Cited by 68
A physiologically-based pharmacokinetic model to describe antisense oligonucleotide distribution after intrathecal administration
Monine, M. I., Norris, D. A., Wang, Y., & Nestorov, I. A. (2021) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-021-09761-0 · Cited by 70
Brain delivery of biologics using a cross‐species reactive transferrin receptor 1 VNAR shuttle
Sehlin, D., Stocki, P., Gustavsson, T., Hultqvist, G., Walsh, F. S., Rutkowski, J. L., & Syvänen, S. (2020) · The FASEB Journal · doi:10.1096/fj.202000610rr · Cited by 64
Drug delivery across the blood-brain barrier for the treatment of pediatric brain tumors – An update
Power, E. A., Rechberger, J. S., Gupta, S. K., Schwartz, J., Daniels, D. J., & Khatua, S. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114303 · Cited by 63
Blood-Brain Barrier Transport, Plasma Pharmacokinetics, and Neuropathology Following Chronic Treatment of the Rhesus Monkey with a Brain Penetrating Humanized Monoclonal Antibody Against the Human Transferrin Receptor
Pardridge, W. M., Boado, R. J., Patrick, D. J., Hui, E. K., & Lu, J. Z. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00730 · Cited by 62
Self-citation
Melanin-like polydopamine nanoparticles mediating anti-inflammatory and rescuing synaptic loss for inflammatory depression therapy
Zhu, T., Wang, H., Gu, H., Ju, L.-S., Wu, X., Pan, W., Zhao, M., Yang, J., & Liu, P.-M. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01807-4 · Cited by 65
Receptor-mediated drug delivery of bispecific therapeutic antibodies through the blood-brain barrier
Pardridge, W. M. (2023) · Frontiers in Drug Delivery · doi:10.3389/fddev.2023.1227816 · Cited by 62
Self-citation
Niosomes decorated with dual ligands targeting brain endothelial transporters increase cargo penetration across the blood-brain barrier
Mészáros, M., Porkoláb, G., Kiss, L., Pilbat, A., Kóta, Z., Kupihár, Z., Kéri, A., Galbács, G., Siklós, L., Tóth, A. J., et al. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.07.042 · Cited by 60
Current and emerging brain applications of MR-guided focused ultrasound
Meng, Y., Suppiah, S., Mithani, K., Solomon, B., Schwartz, M. L., & Lipsman, N. (2017) · Journal of Therapeutic Ultrasound · doi:10.1186/s40349-017-0105-z · Cited by 62
Exosome-like nanoparticles derived from Allium tuberosum prevent neuroinflammation in microglia-like cells
Ishida, T., Kawada, K., Jobu, K., Morisawa, S., Kawazoe, T., Nishimura, S., Akagaki, K., Yoshioka, S., & Miyamura, M. (2023) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgad062 · Cited by 62
Role of histone modifications in neurogenesis and neurodegenerative disease development
Zhao, A., Xu, W., Han, R., Wei, J., Qi, Y., Wang, M., Li, H., Li, M., & Chi, G. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102324 · Cited by 65

Authors: Pardridge, W. M.
Affiliations: University of California, Los Angeles (US)
Corresponding author: Pardridge, William M.
ORCID: Pardridge, William M.
Venue: Expert Opinion on Drug Delivery
Publisher: Informa UK Limited
Published: 2016-04-11
Volume: 13
Issue: 7
Pages: 963-975
ISSN: 1742-5247 (ISSN-L)
1744-7593
DOI: 10.1517/17425247.2016.1171315
OpenAlex: W2314371091
Cited by: 508
References: 88
Citations by year: 2026: 33 · 2025: 45 · 2024: 63 · 2023: 63 · 2022: 84 · 2021: 64 · 2020: 58 · 2019: 37 · 2018: 29 · 2017: 27 · 2016: 4
FWCI: 2.83
Type: journal article
Language: en
Open access: closed
Locations: Expert Opinion on Drug Delivery (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords: cerebrospinal fluid, blood-brain barrier, brain drug delivery, choroid plexus, blood-CSF barrier, drug transport, bulk flow
MeSH terms: Animals, Biological Transport, Blood-Brain Barrier, Brain, Choroid Plexus, Humans, Drug Delivery Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

CSF, blood-brain barrier, and brain drug delivery

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks